Sintx Technologies Framtida tillväxt

Future kriterier kontrolleras 5/6

Sintx Technologies förväntas öka vinsten och intäkterna med 58% och 58.3% per år respektive medan EPS förväntas växa med 71.9% per år.

Viktig information

58.0%

Tillväxttakt i vinsten

71.91%

Tillväxttakt för EPS

Medical Equipment vinsttillväxt	17.1%
Intäkternas tillväxttakt	58.3%
Framtida avkastning på eget kapital	n/a
Bevakning av analytiker	Low
Senast uppdaterad	13 Aug 2026

Senaste uppdateringarna om framtida tillväxt

Recent updates

Ny berättelse • Sep 09

Silicon Nitride Biomaterials And Industrial Orders Will Drive A Turnaround Story

Catalysts About Sintx Technologies Sintx Technologies develops and manufactures advanced silicon nitride based biomaterials and high performance ceramic components for medical and industrial customers. What are the underlying business or industry changes driving this perspective?

Ny berättelse • Aug 26

Silicon Nitride Platform And Contract Manufacturing Orders Will Drive Long-Term Medical Market Upside

Catalysts About Sintx Technologies Sintx Technologies is a biomaterials and medical technology company focused on silicon nitride based components for industrial and medical applications. What are the underlying business or industry changes driving this perspective?

Ny berättelse • Aug 12

High Risk Ceramics Expansion Will Test Outsourced Manufacturing Before Potential Upside Emerges

Catalysts About Sintx Technologies Sintx Technologies develops and manufactures advanced silicon nitride based biomaterials and technical ceramics for medical and industrial customers. What are the underlying business or industry changes driving this perspective?

Analysartikel • Nov 29

It's Unlikely That The CEO Of Sintx Technologies, Inc. (NASDAQ:SINT) Will See A Huge Pay Rise This Year

Key Insights Sintx Technologies' Annual General Meeting to take place on 5th of December CEO B. Bal's total...

Analysartikel • Dec 09

Most Shareholders Will Probably Find That The Compensation For Sintx Technologies, Inc.'s (NASDAQ:SINT) CEO Is Reasonable

Performance at Sintx Technologies, Inc. ( NASDAQ:SINT ) has been rather uninspiring recently and shareholders may be...

Seeking Alpha • Oct 11

SINTX Technologies jumps 25%, gets order for aerospace components

SINTX Technologies (NASDAQ:SINT) has received a production order for silicon nitride components in a critical commercial jet application from a global aerospace manufacturer. The receipt of the order follows a lengthy qualification period which included assessment of company’s operational and quality management systems as well as evaluation of prototypes. Don Bray, VP of Business Development for SINTX commented, “Our silicon nitride manufacturing process is certified to the rigorous AS9100D standard which is a requirement for this application and allowed SINTX to compete for this order. We have several other aerospace and industrial components in evaluation now and expect additional orders in the near future. We believe that our materials technology is very strong, and this aerospace segment is a growth area for SINTX.” Stock rises 25% during pre-market.

Seeking Alpha • Sep 27

SINTX Technologies stock gains 8% premarket on $1.1M grant awarded by US Dept of Energy

SINTX Technologies (NASDAQ:SINT) stock gained 8.1% premarket on Tuesday after the firm announced a phase II award of $1.1M from the U.S. Dept. of Energy. The grant is for development and design of 3D-printed alumina ceramic heat exchangers for heating, ventilation and air conditioning systems (HVAC). The proposal was originally submitted by Technology Assessment and Transfer, which is now a unit of SINT.

Seeking Alpha • Jul 06

SINTX Technologies acquires Technology Assessment and Transfer

Original equipment manufacturer of advanced ceramics, SINTX Technologies (NASDAQ:SINT) acquires Technology Assessment and Transfer, significantly increasing company’s capabilities in the aerospace, defense, and biomedical markets. TA&T, based in Maryland, is a nearly 40-year-old advanced ceramics business that specializes in developing and commercializing a broad array of innovative materials for defense, biomedical, and industrial applications. “We are excited to acquire TA&T and take another step towards diversifying and strengthening SINTX. TA&T will expand our use of advanced manufacturing technologies and introduce new ceramic material platforms to the SINTX portfolio. We expect the acquisition to bring immediate revenue to SINTX via TA&T’s well-established relationships with commercial partners and the U.S. government.” said Dr. Sonny Bal, President and CEO.

Prognoser för vinst- och omsättningstillväxt

NasdaqCM:SINT - Analytikernas framtida uppskattningar och tidigare finansiella data (USD Millions )
Datum	Intäkter	Intäkter	Fritt kassaflöde	Kassaflöde från rörelsen	Genomsnittligt Antal analytiker
12/31/2028	31	-8	N/A	-12	1
12/31/2027	5	-11	N/A	-10	3
12/31/2026	3	-12	N/A	-11	2
6/30/2026	1	-18	-10	-10	N/A
3/31/2026	1	-18	-10	-10	N/A
12/31/2025	1	-17	-9	-9	N/A
9/30/2025	1	-17	-8	-7	N/A
6/30/2025	2	-13	-8	-7	N/A
3/31/2025	3	-12	-8	-7	N/A
12/31/2024	3	-11	-9	-9	N/A
9/30/2024	3	-12	-11	-11	N/A
6/30/2024	3	-9	-12	-11	N/A
3/31/2024	3	-9	-12	-12	N/A
12/31/2023	3	-8	-15	-14	N/A
9/30/2023	2	-14	-14	-13	N/A
6/30/2023	2	-14	-14	-13	N/A
3/31/2023	2	-14	-13	-12	N/A
12/31/2022	2	-16	-12	-10	N/A
9/30/2022	1	-10	-12	-11	N/A
6/30/2022	1	-10	-14	-11	N/A
3/31/2022	1	-10	-14	-10	N/A
12/31/2021	1	-9	-14	-10	N/A
9/30/2021	1	-9	-13	-10	N/A
6/30/2021	0	-9	-10	-10	N/A
3/31/2021	0	-11	-9	-9	N/A
12/31/2020	1	-17	-9	-9	N/A
9/30/2020	1	-16	-9	-9	N/A
6/30/2020	1	-15	-8	-8	N/A
3/31/2020	1	-14	N/A	-8	N/A
12/31/2019	1	-7	N/A	-6	N/A
9/30/2019	1	-8	N/A	-6	N/A
6/30/2019	0	-15	N/A	-7	N/A
3/31/2019	0	-22	N/A	-9	N/A
12/31/2018	0	-24	N/A	-9	N/A
9/30/2018	N/A	-24	N/A	-8	N/A
6/30/2018	-6	-17	N/A	-7	N/A
3/31/2018	-3	-9	N/A	-5	N/A
12/31/2017	N/A	-6	N/A	-5	N/A
9/30/2017	4	-5	N/A	-6	N/A
6/30/2017	13	-15	N/A	-8	N/A
3/31/2017	14	-18	N/A	-8	N/A
12/31/2016	15	-21	N/A	-7	N/A
9/30/2016	17	-22	N/A	-7	N/A
6/30/2016	18	-21	N/A	-6	N/A
3/31/2016	19	-22	N/A	-8	N/A
12/31/2015	19	-24	N/A	-9	N/A
9/30/2015	20	-31	N/A	-10	N/A

Analytiker Framtid Tillväxt Prognoser

Intäkter kontra sparande: SINT förväntas bli lönsam under de kommande 3 åren, vilket anses vara snabbare än sparkvoten ( 3.7% ).

Resultat vs marknad: SINT förväntas bli lönsam under de kommande 3 åren, vilket anses överstiga genomsnittet på marknaden.

Höga tillväxtresultat: SINT förväntas bli lönsam under de kommande 3 åren.

Intäkt vs marknad: SINT s intäkter ( 58.3% per år) förväntas växa snabbare än US marknaden ( 13.4% per år).

Hög tillväxtintäkter: SINT s intäkter ( 58.3% per år) förutspås växa snabbare än 20% per år.

Tillväxtprognoser för vinst per aktie

Framtida avkastning på eget kapital

Framtida ROE: Otillräcklig data för att avgöra om SINT s avkastning på eget kapital förväntas bli hög om tre år

Upptäck tillväxtföretag

Företagsanalys och finansiella data Status

Uppgifter	Senast uppdaterad (UTC-tid)
Analys av företag	2026/09/12 08:50
Aktiekurs vid dagens slut	2026/09/11 00:00
Intäkter	2026/06/30
Årlig intjäning	2025/12/31

Datakällor

Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.

Paket	Uppgifter	Tidsram	Exempel US-källa
Företagets finansiella ställning	10 år	Resultaträkning Kassaflödesanalys Balansräkning	SEC Form 10-K SEC Form 10-Q
Analytikernas konsensusuppskattningar	+3 år	Prognos för finansiella poster Analytikernas prismål	Rapporter från analytiker Blue Matrix
Marknadspriser	30 år	Aktiekurser Utdelningar, splittar och åtgärder	ICE Marknadsdata SEC Form S-1
Ägarskap	10 år	Största aktieägare Insiderhandel	SEC Formulär 4 SEC Formulär 13D
Förvaltning	10 år	Ledningsgrupp Styrelse och verkställande direktörer	SEC Form 10-K SEC Form DEF 14A
Viktiga utvecklingstendenser	10 år	Företagsmeddelanden	SEC Formulär 8-K

^* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.

Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.

Analysmodell och snöflinga

Detaljer om analysmodellen som används för att skapa den här rapporten finns på vår Github-sida, vi har också guider om hur du använder våra rapporter och handledningar på Youtube.

Lär dig mer om det som utformade och byggde analysmodellen Simply Wall St.

Industri- och sektormått

Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.

Källor för analytiker

Sintx Technologies, Inc. bevakas av 7 analytiker. 3 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.

Analytiker	Institution
Edward Woo	Ascendiant Capital Markets LLC
David Turkaly	Citizens JMP Securities, LLC
Brandon Folkes	H.C. Wainwright & Co.

Sintx Technologies Framtida tillväxt

Future kriterier kontrolleras 5/6

Viktig information

Senaste uppdateringarna om framtida tillväxt

SINTX Technologies, Inc. Provides Revenue Guidance for the Third and Fourth Quarters of 2026

Consensus revenue estimates increase by 46%, EPS downgraded

Consensus revenue estimates fall by 29%

Consensus EPS estimates fall by 111%

Price target decreased by 11% to US$25.00

Consensus revenue estimates decrease by 38%, EPS upgraded

Recent updates

Silicon Nitride Biomaterials And Industrial Orders Will Drive A Turnaround Story

Silicon Nitride Platform And Contract Manufacturing Orders Will Drive Long-Term Medical Market Upside

Second quarter 2026 earnings: EPS and revenues miss analyst expectations

SINTX Technologies, Inc. Provides Revenue Guidance for the Third and Fourth Quarters of 2026

High Risk Ceramics Expansion Will Test Outsourced Manufacturing Before Potential Upside Emerges

Sintx Technologies, Inc. to Report Q2, 2026 Results on Aug 11, 2026

New major risk - Financial position

Sintx Technologies, Inc. announced that it has received $4.5 million in funding

Sintx Technologies, Inc. Receives Nasdaq Notice Of Non-Compliance With Listing Rule 5550(b)(1)

Consensus revenue estimates increase by 46%, EPS downgraded

New major risk - Financial position

First quarter 2026 earnings: Revenues exceed analysts expectations while EPS lags behind

Consensus revenue estimates fall by 29%

Full year 2025 earnings: EPS and revenues miss analyst expectations

New major risk - Revenue and earnings growth

New major risk - Market cap size

Sintx Technologies, Inc. Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC Foot & Ankle Implant

Sintx Technologies, Inc. Announces Cessation of Eric Olson as President, Effective March 16, 2026

Sintx Technologies, Inc. Appoints Ryan Elmore as President, Effective March 16, 2026

Consensus EPS estimates fall by 111%

Chief Investment Officer & Director recently bought US$255k worth of stock

Third quarter 2025 earnings: Revenues exceed analysts expectations while EPS lags behind

SINTX Technologies, Inc. Announces Launch of OsseoSculpt an Advanced Biologic for Use with SINAPTIC Foot & Ankle Osteotomy Wedge System

SINTX Technologies, Inc. Strengthens IP Portfolio with New U.S. Patent Notice of Allowance Covering Antipathogenic Fibrous Materials

Sintx Technologies, Inc. has filed a Follow-on Equity Offering in the amount of $6.413876 million.

Price target decreased by 11% to US$25.00

Consensus revenue estimates decrease by 38%, EPS upgraded

SINTX Technologies, Inc. Receives USPTO Notice of Allowance for Silicon Nitride Antipathogenic Platform Patent

New minor risk - Share price stability

Sintx Technologies, Inc. Publishes Study Demonstrating Broad-Spectrum Antiviral Activity of Silicon Nitride

Chief Investment Officer & Director recently bought US$185k worth of stock

Second quarter 2025 earnings: EPS and revenues miss analyst expectations

SINTX Technologies, Inc. Expands Silicon Nitride Platform into Hybrid CFR-PEKK Trauma Plates

SINTX Technologies, Inc. Submits FDA 510(k) for Silicon Nitride Foot & Ankle Medical Devices

Sintx Technologies, Inc. Announces Executive Appointments

Consensus revenue estimates fall by 45%

First quarter 2025 earnings: EPS and revenues miss analyst expectations

Less than half of directors are independent

Sintx Technologies, Inc. Announces Board Changes

Full year 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Sintx Technologies Announces Board Chairman Changes

Sintx Technologies, Inc. announced that it has received $5.000012 million in funding

Tethon Corporation acquired Technology Assessment & Transfer, Inc. from Sintx Technologies, Inc. (NasdaqCM:SINT).

Sintx Technologies, Inc. Appoints Eric K. Olson to the Board of Directors

Insufficient new directors

Sintx Technologies, Inc.Appoints Gregg R. Honigblum as Chief Strategy Officer

Sintx Technologies, Inc., Annual General Meeting, Dec 19, 2024

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Consensus EPS estimates upgraded to US$16.25 loss

Sintx Technologies, Inc. Announces Key Executive Promotions: Ryan Bock, Phd, Named Chief Technology Officer and Ann Kutsch Promoted to President of Sintx Ta&T

Sintx Technologies, Inc. has completed a Follow-on Equity Offering in the amount of $3.114779 million.

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Sintx Technologies, Inc. Announces Appointment of Eric K. Olson as Chief Executive Officer

Sintx Technologies, Inc. has filed a Follow-on Equity Offering in the amount of $3.115475 million.

Consensus EPS estimates fall by 594%

Sintx Technologies Regains Compliance with Nasdaq Bid Price Requirement

Consensus revenue estimates decrease by 12%

Sintx Technologies Declares 1-for-200 Reverse Stock Split Effective May 28, 2024 to Bring it into Compliance with the Minimum Bid Price Requirements for Maintaining the Listing on the Nasdaq Capital Market

First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Sintx Technologies Receives New Notification Letter from Nasdaq Regarding Non-Compliance with the Minimum Bid Price Requirement for Continued Listing on The Nasdaq Capital Market

Sintx Technologies, Inc. has filed a Follow-on Equity Offering.

Full year 2023 earnings: EPS misses analyst expectations

Sintx Technologies, Inc. has completed a Follow-on Equity Offering in the amount of $1.030519 million.

Consensus revenue estimates increase by 17%

Sintx Technologies, Inc. Provides Estimated Revenue for the Fourth Quarter and Full Year Ended December 31, 2023

It's Unlikely That The CEO Of Sintx Technologies, Inc. (NASDAQ:SINT) Will See A Huge Pay Rise This Year

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Sintx Technologies, Inc., Annual General Meeting, Dec 05, 2023

SINTX Technologies Receives a Notice from Nasdaq Listing Qualifications Department of the Nasdaq Stock Market